DK1012181T3 - Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom - Google Patents

Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom

Info

Publication number
DK1012181T3
DK1012181T3 DK98931729T DK98931729T DK1012181T3 DK 1012181 T3 DK1012181 T3 DK 1012181T3 DK 98931729 T DK98931729 T DK 98931729T DK 98931729 T DK98931729 T DK 98931729T DK 1012181 T3 DK1012181 T3 DK 1012181T3
Authority
DK
Denmark
Prior art keywords
preparations
diagnosis
prevention
surface antigens
lyme disease
Prior art date
Application number
DK98931729T
Other languages
Danish (da)
English (en)
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of DK1012181T3 publication Critical patent/DK1012181T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK98931729T 1997-06-30 1998-06-29 Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom DK1012181T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30

Publications (1)

Publication Number Publication Date
DK1012181T3 true DK1012181T3 (da) 2007-01-02

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98931729T DK1012181T3 (da) 1997-06-30 1998-06-29 Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom

Country Status (17)

Country Link
US (2) US6660274B2 (de)
EP (1) EP1012181B1 (de)
JP (1) JP2002511760A (de)
KR (1) KR20010020567A (de)
CN (1) CN1261896A (de)
AR (1) AR016295A1 (de)
AT (1) ATE337335T1 (de)
AU (1) AU8177298A (de)
CA (1) CA2294701C (de)
CO (1) CO4790101A1 (de)
DE (1) DE69835682T2 (de)
DK (1) DK1012181T3 (de)
ES (1) ES2270523T3 (de)
NO (1) NO996514L (de)
PL (1) PL337667A1 (de)
WO (1) WO1999000413A1 (de)
ZA (1) ZA985704B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437116B1 (en) 1996-02-21 2002-08-20 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic borrelia
DK1012181T3 (da) * 1997-06-30 2007-01-02 Univ Tulane Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
EP2292762A3 (de) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System VMP-artige Sequenzen von krankheitserregenden Borrelienspezies und -stämmen
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
BRPI0719360B1 (pt) 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
US8247181B2 (en) 2007-09-07 2012-08-21 The Regents Of The University Of California Borrelia diagnostics and screening methods
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
AU2010322085B2 (en) * 2009-11-17 2016-09-15 Zoetis Services Llc Peptides and methods for the detection of Lyme disease antibodies
EP3705133B1 (de) * 2010-05-14 2024-06-26 Baxalta Incorporated Ospa-chimären und verwendung davon in impfstoffen
RU2013118647A (ru) 2010-09-27 2014-11-10 Корнелл Юниверсити Способы диагностики болезни лайма
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease
EP3341730A1 (de) 2015-08-27 2018-07-04 Quidel Corporation Immunassaytestvorrichtung mit zwei fluidflusswegen zur detektion und differenzierung von zwei oder mehreren analyten
FI3353551T3 (fi) * 2015-09-25 2023-01-31 Koostumuksia ja menetelmiä lymen taudin diagnosoimiseksi ja lymen tautia aiheuttavan spirokeetan eliminaation ennustamiseksi hoidon jälkeen
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN110573880B (zh) 2017-02-10 2023-05-16 奎多公司 具有受控流体流动通道的基底的横向流动测试
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (de) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen Verfahren zur Herstellung eines antigenen bzw. immunogenen Konjugats sowie die Verwendung solcher Konjugate
AU7058691A (en) 1989-12-22 1991-07-24 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
ATE142888T1 (de) 1990-03-05 1996-10-15 Us Health Antigen-wirkende proteine von borrelia burgdorferi
JPH06501382A (ja) 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
EP1016416A3 (de) * 1990-07-06 2002-10-23 Wyeth Impfstoff gegen die Lyme-Krankheit und Modell zur Überwachung der Impfstoffwirksamkeit
US6437116B1 (en) * 1996-02-21 2002-08-20 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic borrelia
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
DK1012181T3 (da) * 1997-06-30 2007-01-02 Univ Tulane Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
EP1012181B1 (de) 2006-08-23
US20040067517A1 (en) 2004-04-08
ATE337335T1 (de) 2006-09-15
AR016295A1 (es) 2001-07-04
AU8177298A (en) 1999-01-19
PL337667A1 (en) 2000-08-28
ES2270523T3 (es) 2007-04-01
CA2294701C (en) 2009-09-08
EP1012181A1 (de) 2000-06-28
ZA985704B (en) 1999-01-13
JP2002511760A (ja) 2002-04-16
NO996514L (no) 2000-02-14
NO996514D0 (no) 1999-12-28
WO1999000413A1 (en) 1999-01-07
CO4790101A1 (es) 1999-05-31
DE69835682D1 (de) 2006-10-05
US6660274B2 (en) 2003-12-09
CA2294701A1 (en) 1999-01-07
US20030059894A1 (en) 2003-03-27
DE69835682T2 (de) 2007-08-23
CN1261896A (zh) 2000-08-02
KR20010020567A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
DK1012181T3 (da) Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom
ITRM950140A0 (it) Dispositivo simmetrizzatore e procedimento per la sua progettazione.
DE69634858D1 (de) Nichtinvasive blutuntersuchungsvorrichtung
DE69529245D1 (de) Nicht-invasiver Blutanalysator
NO973287D0 (no) Innåndingsbar væske - eliminasjonsanalyse
FI894065L (fi) Humanrhinovirusreceptorprotein som haemmar infektionsfoermaogan hos virus.
DE69715584D1 (de) Bilderzeugungsgerät und -Verfahren
DE69736457D1 (de) Interatomares messverfahren
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
FI962844L (fi) T-soluantigeenireseptorin V-alueen proteiineja ja menetelmiä niiden valmistamiseksi
DK0818140T3 (da) Blokfremstillingsindretning
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
ATE300235T1 (de) Blutentnahmevorrichtung
DE69926012D1 (de) Arzneizubereitungen
DE69906934D1 (de) Arzneizubereitungen
DE69815434D1 (de) Bilderzeugungsvorrichtung und -verfahren
DE69712899D1 (de) Diagnose von präe-eklampsie
NO20003333D0 (no) Filtre
ITMI920870A0 (it) Poliestereimmide trmotropica, procedimento per la sua preparazione e suo impiego
EP1042346A4 (de) 86 menschliche sekretierte proteine
NO20002832D0 (no) Humantyroidprotein ZSig45 og DNA som koder for dette
SE9702117D0 (sv) Blodanalyssystem
SE9804221D0 (sv) Förfarande för blodmikrospektralanalys
ITMI911634A0 (it) Sostanza proteica e procedimento per la sua preparazione
SE9704536D0 (sv) Förfarande för blodmikrospektralanalys